These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

29 related articles for article (PubMed ID: 8218682)

  • 1. Clinical development of a new inactivated hepatitis A vaccine.
    Vidor E; Fritzell B; Plotkin S
    Infection; 1996; 24(6):447-58. PubMed ID: 9007593
    [No Abstract]   [Full Text] [Related]  

  • 2. Active versus passive immunization against hepatitis A in the Israel defence forces: a cost-benefit analysis.
    Gillis D; Yetiv N; Gdalevich M; Mimouni D; Ashkenazi I; Shpilberg O; Eldad A; Shemer J
    Vaccine; 2000 Jul; 18(26):3005-10. PubMed ID: 10825603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute non-B hepatitis in the Israel Defence Forces: comparison of some epidemiologic features before and after the usage of preexposure immune serum globulin prophylaxis.
    Matzkin H
    Hepatology; 1987; 7(6):1330-2. PubMed ID: 3119454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The three-year incidence of non-B viral hepatitis morbidity in a controlled trial of pre-exposure immune serum globulin prophylaxis.
    Kark JD; Witztum E; Mazkin H; Nili E; Danon YL
    Infection; 1984; 12(4):251-5. PubMed ID: 6386693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pre-exposure prophylaxis of viral hepatitis with immune serum globulin in an endemic area. A trial in field units of the Israel Defence Forces.
    Kark JD
    Scand J Infect Dis; 1983; 15(1):3-6. PubMed ID: 6405480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does immune serum globulin confer protection against skin diseases?
    Mimouni D; Gdalevich M; Mimouni FB; Grotto I; Eldad A; Shpilberg O
    Int J Dermatol; 2000 Aug; 39(8):628-31. PubMed ID: 10971736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of different doses of immune serum globulin in the prevention of hepatitis A: a three-year prospective study.
    Lerman Y; Shohat T; Ashkenazi S; Almog R; Heering SL; Shemer J
    Clin Infect Dis; 1993 Sep; 17(3):411-4. PubMed ID: 8218682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis A and the American traveler.
    Wolfe MS
    J Infect Dis; 1995 Mar; 171 Suppl 1():S29-32. PubMed ID: 7876645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Host immune response to hepatitis A virus.
    Stapleton JT
    J Infect Dis; 1995 Mar; 171 Suppl 1():S9-14. PubMed ID: 7876654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prophylactic treatment regimens for the prevention of hepatitis A. Current concepts.
    Kendall BJ; Cooksley WG
    Drugs; 1991 Jun; 41(6):883-8. PubMed ID: 1715265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preventing the spread of viral hepatitis.
    Frymoyer CL
    Am Fam Physician; 1993 Dec; 48(8):1479-86. PubMed ID: 8249779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Review: hepatitis B immune globulin for prevention of hepatitis B infection.
    Zuckerman JN
    J Med Virol; 2007 Jul; 79(7):919-21. PubMed ID: 17516515
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.